Pikoulas Antonis, Piperaki Evangelia-Theophano, Spanakos Gregory, Kallianos Anastasios, Mparmparousi Despoina, Rentziou Gianna, Trakada Georgia
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Department of Medicine, University of Crete and Foundation for Research and Technology, Heraklion, Greece.
IDCases. 2022;27:e01358. doi: 10.1016/j.idcr.2021.e01358. Epub 2021 Dec 6.
As the COVID-19 pandemic spreads across the globe, it will undoubtedly cross paths with long endemic infectious diseases in different areas. Interactions between SARS-CoV2 and well-known pathogens will likely give rise to unfamiliar clinical presentations, depending on complex and as yet unknown immunological interactions. We present a case of coinfection with COVI19 and visceral leishmaniasis and discuss recent reports regarding coexistence of SARS-CoV2 and spp. to date.
随着新冠疫情在全球蔓延,它无疑会在不同地区与长期流行的传染病相遇。新型冠状病毒(SARS-CoV2)与知名病原体之间的相互作用可能会导致出现不熟悉的临床表现,这取决于复杂且尚不清楚的免疫相互作用。我们报告一例新冠病毒与内脏利什曼病合并感染的病例,并讨论迄今为止有关SARS-CoV2与其他病原体共存的最新报道。